
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune targets in the tumor microenvironment treated by radiotherapy
Omer M. Ozpiskin, Lu Zhang, Jian Jian Li
Theranostics (2019) Vol. 9, Iss. 5, pp. 1215-1231
Open Access | Times Cited: 128
Omer M. Ozpiskin, Lu Zhang, Jian Jian Li
Theranostics (2019) Vol. 9, Iss. 5, pp. 1215-1231
Open Access | Times Cited: 128
Showing 1-25 of 128 citing articles:
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 420
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 420
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 359
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 359
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang, Ningning Guo, Yi Zhou, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2156-2170
Open Access | Times Cited: 308
Qiyao Yang, Ningning Guo, Yi Zhou, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2156-2170
Open Access | Times Cited: 308
Role of tumor microenvironment in cancer progression and therapeutic strategy
Qingjing Wang, Xueting Shao, Yuxuan Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11149-11165
Open Access | Times Cited: 172
Qingjing Wang, Xueting Shao, Yuxuan Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11149-11165
Open Access | Times Cited: 172
Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
Yuxuan Peng, Shuang Liang, Qian‐Fang Meng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 22
Yuxuan Peng, Shuang Liang, Qian‐Fang Meng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 22
Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis
Tuo Hu, Huashan Liu, Zhenxing Liang, et al.
Theranostics (2020) Vol. 10, Iss. 9, pp. 4056-4072
Open Access | Times Cited: 111
Tuo Hu, Huashan Liu, Zhenxing Liang, et al.
Theranostics (2020) Vol. 10, Iss. 9, pp. 4056-4072
Open Access | Times Cited: 111
Damage-associated molecular patterns in tumor radiotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106761-106761
Closed Access | Times Cited: 98
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106761-106761
Closed Access | Times Cited: 98
Integrin αvβ3-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy
Haojun Chen, Liang Zhao, Kaili Fu, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7948-7960
Open Access | Times Cited: 83
Haojun Chen, Liang Zhao, Kaili Fu, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7948-7960
Open Access | Times Cited: 83
Radiation-induced small extracellular vesicles as “carriages” promote tumor antigen release and trigger antitumor immunity
Wanzun Lin, Yanyan Xu, Xiaochuan Chen, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 4871-4884
Open Access | Times Cited: 78
Wanzun Lin, Yanyan Xu, Xiaochuan Chen, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 4871-4884
Open Access | Times Cited: 78
Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives
Xiaotong Chen, Ju Yang, Lifeng Wang, et al.
Theranostics (2020) Vol. 10, Iss. 13, pp. 6011-6023
Open Access | Times Cited: 77
Xiaotong Chen, Ju Yang, Lifeng Wang, et al.
Theranostics (2020) Vol. 10, Iss. 13, pp. 6011-6023
Open Access | Times Cited: 77
Modulation of the tumor microenvironment (TME) by melatonin
Mu Qi, Masoud Najafi
European Journal of Pharmacology (2021) Vol. 907, pp. 174365-174365
Closed Access | Times Cited: 68
Mu Qi, Masoud Najafi
European Journal of Pharmacology (2021) Vol. 907, pp. 174365-174365
Closed Access | Times Cited: 68
Exosomal transfer of tumor-associated macrophage-derived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer
Xiaobin Gu, Yonggang Shi, Meilian Dong, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 9
Open Access | Times Cited: 63
Xiaobin Gu, Yonggang Shi, Meilian Dong, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 9
Open Access | Times Cited: 63
Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy
Qi Shang, Yabing Dong, Yun Su, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114308-114308
Closed Access | Times Cited: 50
Qi Shang, Yabing Dong, Yun Su, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114308-114308
Closed Access | Times Cited: 50
Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect
Furong Cheng, Ting Su, Shurong Zhou, et al.
Science Advances (2023) Vol. 9, Iss. 28
Open Access | Times Cited: 40
Furong Cheng, Ting Su, Shurong Zhou, et al.
Science Advances (2023) Vol. 9, Iss. 28
Open Access | Times Cited: 40
Particle radiotherapy in the era of radioimmunotherapy
Zihan Zhou, Bingjie Guan, Huang Xia, et al.
Cancer Letters (2023) Vol. 567, pp. 216268-216268
Closed Access | Times Cited: 26
Zihan Zhou, Bingjie Guan, Huang Xia, et al.
Cancer Letters (2023) Vol. 567, pp. 216268-216268
Closed Access | Times Cited: 26
Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells
Shi Zheng, Cuilan Hu, Xiaogang Zheng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Shi Zheng, Cuilan Hu, Xiaogang Zheng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 8
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 8
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects
Zahid Rafiq, M.J. Kang, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Zahid Rafiq, M.J. Kang, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
The yin and yang of imaging tumor associated macrophages with PET and MRI
Sudip Mukherjee, Dominik Sonanini, Andreas Maurer, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7730-7748
Open Access | Times Cited: 65
Sudip Mukherjee, Dominik Sonanini, Andreas Maurer, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7730-7748
Open Access | Times Cited: 65
The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106807-106807
Closed Access | Times Cited: 64
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106807-106807
Closed Access | Times Cited: 64
Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade
Xinrui Zhao, Chunlin Shao
Cancers (2020) Vol. 12, Iss. 10, pp. 2762-2762
Open Access | Times Cited: 62
Xinrui Zhao, Chunlin Shao
Cancers (2020) Vol. 12, Iss. 10, pp. 2762-2762
Open Access | Times Cited: 62
The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy
Zihao Li, Yue Li, Jing Gao, et al.
Life Sciences (2021) Vol. 273, pp. 119150-119150
Closed Access | Times Cited: 48
Zihao Li, Yue Li, Jing Gao, et al.
Life Sciences (2021) Vol. 273, pp. 119150-119150
Closed Access | Times Cited: 48
Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
Qin Wang, Shangbiao Li, Simiao Qiao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
Qin Wang, Shangbiao Li, Simiao Qiao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
Song-Xin Zhu, Yuming Wang, Jun Tang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Song-Xin Zhu, Yuming Wang, Jun Tang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Advances in Engineering Cells for Cancer Immunotherapy
Xiao Xu, Teng Li, Shiyang Shen, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7889-7905
Open Access | Times Cited: 49
Xiao Xu, Teng Li, Shiyang Shen, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7889-7905
Open Access | Times Cited: 49